/PRNewswire/ Intrinsic, an emerging leader in the health & wellness eCommerce space, has closed $113 million in Series A funding led by Define Ventures with.
Intrinsic, a NYC-based health & wellness eCommerce company, raised $113m in Series A funding.
The round, which brought total raise to $115m, was led by Define Ventures with participation from Link Ventures and others. In conjunction with the funding, Lynne Chou O’Keefe, Partner, Define Ventures, joined Intrinsic’s board of directors.
Founded earlier this year in partnership with Redesign Health, a healthcare innovation platform, Intrinsic is an acquisition and growth platform focused on eCommerce native health & wellness brands selling on Amazon and other eCommerce channels. The company focuses on numerous areas of health & wellness, including Pregnancy & Baby, Healthy Aging, Orthopedics, Digestive Health, Immune Support, Eye Health and Skin Care, bringing capital, healthcare marketing expertise, supply chain expertise, and advanced analytics.
AlleyWatch
Armed with some data from our friends at CrunchBase, I broke down the largest US startup funding rounds from January 2021. I have included some additional information such as industry, company description, round type, founders, and total equity funding raised to further the analysis. The TechWatch Media Group audience is driving progress and innovation on a global scale. With its regional media properties (NYC Tech, LA Tech, London Tech, Paris Tech, Boston Tech) TechWatch Media Group is the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including strategic brand placement in a high-visibility, lead generation, and building thought leadership among the vast majority of key influencers in the business community and beyond. Learn more about running a digital campaign that will return your investment here.
By Christina Farr Jan. 26, 2021Reprints
Adobe
Silicon Valley types like to talk about disrupting things. But health care doesn’t want to be disrupted.
I get it. Who wants to see their medical care taken over by a bunch of techies willing to cut corners in their insatiable quest for growth? If Theranos’ Elizabeth Holmes had continued to operate her business without oversight, who knows how many people would have been hurt?
Lately, I’ve been feeling that it’s time for us to move on from the narrative that a bunch of brash newcomers are moving into the health tech space and willfully harming people because they don’t respect the rules. To be sure, there are bad actors in health tech, just as there are in any sector. Instead, it’s time to consider a more nuanced alternative to this story.